mHealth Intervention for Dementia Prevention through lifestyle Optimisation (MIND-PRO): a hybrid effectiveness-implementation randomized controlled trial in middle-aged persons with low SES and/or migration background

Amsterdam University Medical Centers0 sites692 target enrollmentMarch 4, 2024

Overview

Phase: 未知
Intervention: Not specified
Conditions: owering dementia risk factors in people with elevated dementia risk
Sponsor: Amsterdam University Medical Centers
Enrollment: 692
Status: Active, not recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

March 4, 2024

End Date

December 31, 2026

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

Amsterdam University Medical Centers

•Current inclusion criteria as of 05/06/2024:
•1\. Age \=50 years \=75 years
•2\. Basic level of literacy in Dutch
•3\. Possession of a smartphone
•4\. Turkish or South\-Asian Surinamese background; OR Dutch background with low SES, operationalised using educational level and occupational status
•5\. Increased risk of dementia based on \= one dementia risk factor defined as:
•5\.1\. Hypertension, defined by any of the following:
•5\.1\.1\. Diagnosis by specialist or general practitioner.
•5\.1\.2\. Currently on anti\-hypertensive drugs.
•5\.1\.3\. Baseline blood pressure: \=140/90 mmHg;

•1\. Diagnosed with dementia by a specialist or general practitioner
•2\. A score below 21 on the Rowland Universal Dementia Assessment Scale (RUDAS) validated dementia screening method specifically developed to be less susceptible to cultural, linguistic, and educational biases
•3\. Any condition expected to limit 12 months of compliance and follow\-up, including metastasised malignancy or other terminal illness
•4\. Any impairment interfering with the operation of a smartphone
•5\. Participating in another RCT on lifestyle behavioural change
•6\. Present alcohol or illicit drug abuse impairing study participation